Lek Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LEK PHARM, and what generic and branded alternatives to LEK PHARM drugs are available?
LEK PHARM has three approved drugs.
There are two tentative approvals on LEK PHARM drugs.
Summary for Lek Pharm
US Patents: | 0 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 3 |
Patent Litigation for Lek Pharm: | See patent lawsuits for Lek Pharm |
Drugs and US Patents for Lek Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lek Pharm | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | CAPSULE;ORAL | 075100-001 | Dec 10, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Lek Pharm | ACYCLOVIR | acyclovir | TABLET;ORAL | 074658-001 | Apr 22, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Lek Pharm | ACYCLOVIR | acyclovir | CAPSULE;ORAL | 074750-001 | Apr 22, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Lek Pharm | ACYCLOVIR | acyclovir | TABLET;ORAL | 074658-002 | Apr 22, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.